BR0110512A - Preparação para medir a taxa de esvaziamento gástrico - Google Patents

Preparação para medir a taxa de esvaziamento gástrico

Info

Publication number
BR0110512A
BR0110512A BR0110512-4A BR0110512A BR0110512A BR 0110512 A BR0110512 A BR 0110512A BR 0110512 A BR0110512 A BR 0110512A BR 0110512 A BR0110512 A BR 0110512A
Authority
BR
Brazil
Prior art keywords
stomach
rate
preparation
eliminative
preparations
Prior art date
Application number
BR0110512-4A
Other languages
English (en)
Inventor
Shinsuke Nakagawa
Keigo Yamada
Masateru Miyake
Makoto Inada
Nobuhiro Ikei
Atsunari Noda
Hideji Nonomura
Original Assignee
Otsuka Pharma Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Otsuka Pharma Co Ltd filed Critical Otsuka Pharma Co Ltd
Publication of BR0110512A publication Critical patent/BR0110512A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/12—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by a special physical form, e.g. emulsion, microcapsules, liposomes, characterized by a special physical form, e.g. emulsions, dispersions, microcapsules
    • A61K51/1206—Administration of radioactive gases, aerosols or breath tests
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/12—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by a special physical form, e.g. emulsion, microcapsules, liposomes, characterized by a special physical form, e.g. emulsions, dispersions, microcapsules

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Dispersion Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Optics & Photonics (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Physics & Mathematics (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Atmospheric Sciences (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
  • Investigating Or Analysing Biological Materials (AREA)

Abstract

"PREPARAçãO PARA MEDIR A TAXA DE ESVAZIAMENTO GáSTRICO". Preparações pelas quais redução ou aceleração da taxa eliminativa do estómago podem ser avaliadas de modo não-invasivo; e um método para avaliar a taxa eliminativa do estómago por uso destas preparações. Assim, a redução ou aceleração da taxa eliminativa do estómago pode ser examinada de modo seguro e conveniente. Ou seja, estas preparações são utilizáveis para diagnosticar de modo objetivo a função motora do estómago, assim como para avaliar e julgar o efeito da droga ou efeito terapêutico de uma droga com relação à função motora do estómago em pacientes individuais.
BR0110512-4A 2000-05-02 2001-04-25 Preparação para medir a taxa de esvaziamento gástrico BR0110512A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2000133691 2000-05-02
PCT/JP2001/003549 WO2001082979A1 (fr) 2000-05-02 2001-04-25 Preparations permettant d'evaluer la capacite d'elimination de l'estomac

Publications (1)

Publication Number Publication Date
BR0110512A true BR0110512A (pt) 2004-03-09

Family

ID=18642127

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0110512-4A BR0110512A (pt) 2000-05-02 2001-04-25 Preparação para medir a taxa de esvaziamento gástrico

Country Status (10)

Country Link
US (2) US7018613B2 (pt)
EP (1) EP1285668A4 (pt)
KR (1) KR20030007567A (pt)
CN (1) CN1427728A (pt)
AU (2) AU5255901A (pt)
BR (1) BR0110512A (pt)
CA (1) CA2409223A1 (pt)
MX (1) MXPA02010852A (pt)
TW (1) TWI268780B (pt)
WO (1) WO2001082979A1 (pt)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU7458501A (en) * 2000-06-21 2002-01-02 Otsuka Pharma Co Ltd Preparations for measruing gastric ph value and method of measuring gastric ph value by using the same
JP2006508334A (ja) * 2002-06-28 2006-03-09 オリディオン ブレシド リミティド 胃腸障害の管理
CN101232905B (zh) * 2005-07-25 2013-01-09 大塚制药株式会社 一种用于测量嘧啶代谢能力的口服制剂
CA2649262A1 (en) * 2006-04-13 2007-10-25 Otsuka Pharmaceutical Co., Ltd. Test agent for diagnosing dyspepsia
US20090180956A1 (en) * 2006-05-01 2009-07-16 Asuka Ito Diagnostic for evaluating gastric evacuation function and/or small intestinal absorption function
GB2442980B (en) * 2006-10-18 2011-11-23 Autoliv Dev Improvements in or relating to detection of substances in a subject
WO2012023590A1 (ja) * 2010-08-19 2012-02-23 大塚製薬株式会社 13ｃ炭酸塩を用いた胃内酸度の定量的測定方法
CN104737016B (zh) 2012-08-20 2017-09-29 大塚制药株式会社 测定糖代谢能力的方法及用于该方法的组合物
ES2754246T3 (es) 2013-03-15 2020-04-16 Otsuka Pharma Co Ltd Composición para su uso en un método para medir la razón de combustión azúcar/ácido graso
US20200182856A1 (en) * 2016-11-25 2020-06-11 Otsuka Pharmaceutical Co., Ltd. Method of Evaluating Nutriture
CN109078197A (zh) * 2018-09-12 2018-12-25 江苏省原子医学研究所 一种新型胃排空测定方法

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4451260A (en) * 1982-03-26 1984-05-29 Minnesota Mining And Manufacturing Company Sustained release oral medicinal delivery device
US4830010A (en) * 1986-04-04 1989-05-16 Marshall Barry J Methods for the diagnosis of gastrointestinal disorders
US5164308A (en) * 1990-05-21 1992-11-17 Martek Corporation Preparation of labelled triglyceride oils by cultivation of microorganisms
US5233997A (en) * 1991-04-04 1993-08-10 Baylor College Of Medicine Non-invasive measure of intestinal transit time and uses thereof
SE504902C2 (sv) * 1994-11-02 1997-05-26 Diabact Ab Beredning för påvisande av Helicobacter pylori i magsäcken
WO1996036330A2 (en) 1995-05-17 1996-11-21 Cedars-Sinai Medical Center Compositions containing fatty acids for improving digestion and absorption in the small intestine
US5707602A (en) * 1996-03-25 1998-01-13 Meretek Diagnostics Measurement of gastric emptying
CN1087178C (zh) * 1996-08-13 2002-07-10 协和发酵工业株式会社 同位素标记的尿素片
US5785949A (en) * 1996-09-05 1998-07-28 Meretek Diagnostics Measurement of liquid phase gastric emptying
US6186958B1 (en) * 1997-02-26 2001-02-13 Oridion Medical Breath test analyzer
CA2250485C (en) * 1997-10-21 2008-04-29 Tokyo Gas Co., Ltd. Diagnostic agent for diabetes
US6740305B1 (en) * 1999-04-09 2004-05-25 Xanthus Life Scienes, Inc. Assessment of gastric emptying disorders
CA2369484A1 (en) * 1999-04-09 2000-10-19 Xanthus Life Sciences, Inc. Assessment of gastric emptying disorders

Also Published As

Publication number Publication date
EP1285668A4 (en) 2007-07-11
TWI268780B (en) 2006-12-21
MXPA02010852A (es) 2003-07-14
US20060153771A1 (en) 2006-07-13
EP1285668A1 (en) 2003-02-26
CA2409223A1 (en) 2002-11-18
WO2001082979A1 (fr) 2001-11-08
KR20030007567A (ko) 2003-01-23
CN1427728A (zh) 2003-07-02
AU5255901A (en) 2001-11-12
AU2001252559B2 (en) 2005-09-15
US20030190283A1 (en) 2003-10-09
US7018613B2 (en) 2006-03-28

Similar Documents

Publication Publication Date Title
FNLAY Pharmacokinetics of terbinafine in the nail
NO996229L (no) Heparanase spesifikke molekylære prober og deres anvendelse i forskning og medisin
EP1938748A3 (en) Device and method for segmental bioimpedance measurements of a dialysis patient
BRPI0510274B8 (pt) uso de um agente para tratar ou prevenir doença celíaca, composição farmacêutica compreendendo dito agente, método de diagnóstico de doença celíaca, ou suscetibilidade à doença celíaca, uso do dito agente para a preparação de um meio de diagnóstico e kit para realizar o dito método de diagnóstico
BR0110512A (pt) Preparação para medir a taxa de esvaziamento gástrico
BR0110091A (pt) Composições e processos para terapia e diagnóstico de câncer de mama
BR0110748A (pt) Plataforma de nanodispositivo multifuncional
ES2138729T3 (es) Metodos de diagnostico de la preeclampsia.
HUP0202779A2 (hu) Immunológiai eljárás szöveti transzglutamináz (tTG) elleni antitestek kimutatására, tTG alkalmazása diagnosztikai célokra és terápiás ellenőrzésre, valamint tTG-t tartalmazó orális gyógyászati hatóanyag
HUP0101994A2 (hu) Eszköz valamely gyógyszervegyület vérparaméterekre gyakorolt hatásainak in vivo meghatározására, valamint alkalmazása
BR0014652A (pt) Fabricação de conjugados de agente terapêutico-poliglutamato
WO2002054946A3 (en) Ultrasonic imaging of perfusion using gases with different partial pressures
HUP0102479A2 (hu) Neisseria meningitidis-ből származó BASBO29-polinukleotid(ok) és polipeptidek
EP1335021A4 (en) GENOMS INVOLVED IN RHEUMATOID ARTHRITIS, METHOD FOR DIAGNOSIS THEREOF, METHOD FOR EVALUATING THE POSSIBILITY OF AN OUTBREAK THEREOF, DIAGNOSTIC KIT FOR DETECTING THESE GENES, THERAPEUTIC METHOD AND MEDICINE FOR ARTHRUME
AU2002210926A1 (en) Genomes participating in rheumatoid arthritis, method of the diagnosis thereof, method of evaluating the onset possibility thereof, diagnostic kit for detecting them and therapeutic method and remedies for rheumatoid arthritis
BRPI0412430A (pt) polipeptìdeo agonista do receptor de zot e zonulina
EP1393738A4 (en) MEDICINE AGAINST DIABETES
BR0111726A (pt) Derivados de biotina
BRPI0415695A8 (pt) agente imunoterápico útil para o tratamento combinado de tuberculose em associação com outras drogas
BR9007757A (pt) Diagnostico e tratamento de disturbios neuro-cognitivos associados com disfuncoes imunologicas sistemicas
WO2002082077A3 (de) Herstellung polyklonaler, monospezifischer antikörper gegen die upar-varianten del4, del5 und del4+5 sowie deren verwendung für diagnostische und therapeutische zwecke
Cusini et al. Unilateral Darier's disease associated with Hodgkin's lymphoma.
BRPI0510510B8 (pt) espuma ativada feita de uma borracha natural ou sintética ou de uma resina sintética
Shemer et al. Oral terbinafine in the treatment of onychomycosis: a comparison of continuous and extended-pause regimens.
UA38037A (uk) Спосіб визначення уражень структур блукаючого нерва при абдомінальній патології

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 8A ANUIDADE.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO DA RPI 2016 DE 25/08/2009.